The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Cogent Biosciences, Inc.(NASDAQ:COGT)

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well...
Share this website to your friends
Cogent Biosciences . Days Payable Outstanding ttm (DPO)
Cogent Biosciences . Op Cashflow Per Share ttm
Cogent Biosciences . Free Cashflow Per Share ttm
Cogent Biosciences . Cash Per Share ttm
Cogent Biosciences . P/S ratio ttm
Cogent Biosciences . (GAAP) P/E ratio ttm
Cogent Biosciences . P/B ratio ttm
No extra charts and metrics for this ticker.
